Showing results (361-370 of 416) with videos related to
Sort By:
Pageof 42
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 14, 2016
A proof-of-concept trial of protein kinase C iota inhibition with auranofin for the paclitaxel-induced acute pain syndromeAminah Jatoi, Megan E Grudem, Travis J Dockter, et al.Ophthalmology|December 12, 2023
Association of Sociodemographic Characteristics with Pediatric Vision Screening and Eye Care: An Analysis of the 2021 National Survey of Children's HealthBani Antonio-Aguirre, Sandra S Block, Afua O Asare, et al.Mayo Clinic Proceedings|February 1, 2016
Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic MelanomaMariah L White, Thomas D Atwell, A Nicholas Kurup, et al.Annals of Surgical Oncology|May 30, 2026
Accuracy of Index Lymph Node Pathology in Predicting Overall Response to Neoadjuvant Immunotherapy for Clinical Stage III Melanoma: Results From the Prospective NeoACTIVATE Arm C (NCT03554083) SubstudyTina J Hieken, Thomas J Flotte, David Zahrieh, et al.British Journal of Cancer|June 3, 2016
Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancerChen Wang, Boris J Winterhoff, Kimberly R Kalli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2018
Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer PatientsKimberly R Kalli, Matthew S Block, Pashtoon M Kasi, et al.JCI Insight|January 25, 2019
A recombinant human IgG1 Fc multimer designed to mimic the active fraction of IVIG in autoimmunityXiaoyu Zhang, Jane Owens, Henrik S Olsen, et al.Journal of Child and Adolescent Psychopharmacology|October 31, 2006
Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trialElizabeth Berry-Kravis, Sue Ellen Krause, Sandra S Block, et al.JCI Insight|May 17, 2016
T cell Bim levels reflect responses to anti-PD-1 cancer therapyRoxana S Dronca, Xin Liu, Susan M Harrington, et al.Journal for Immunotherapy of Cancer|November 2, 2023
Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockadeYan Luo, Barath Shreeder, James W Jenkins, et al.Pageof 42